GABARAPL2 and obesity disorder: Among the genes, GABARAPL2 is associated with total and high‐density lipoprotein–cholesterol (Capel et al., 2008), and SETDB1 is an antiadipogenic factor playing a role in obesity (Okamura et al., 2010).